Fusion Antibodies.
87 announcements.
87 announcements.
| Time | Date | Ticker | Company | Announcement |
|---|---|---|---|---|
| 07:00 | 11-12-2025 | FAB | Fusion Antibodies | Mammalian Display video |
| 12:11 | 25-11-2025 | FAB | Fusion Antibodies | Holding(s) in Company |
| 07:00 | 24-11-2025 | FAB | Fusion Antibodies | Half-year Financial Report |
| 07:00 | 21-11-2025 | FAB | Fusion Antibodies | Notice of Results |
| 07:00 | 13-11-2025 | FAB | Fusion Antibodies | OptiMAL Library video |
| 07:00 | 03-11-2025 | FAB | Fusion Antibodies | OptiMAL® R&D Update |
| 15:38 | 27-10-2025 | FAB | Fusion Antibodies | Holding(s) in Company |
| 13:31 | 16-10-2025 | FAB | Fusion Antibodies | Result of AGM |
| 07:00 | 16-10-2025 | FAB | Fusion Antibodies | AGM statement and H1 trading update |
| 07:00 | 08-10-2025 | FAB | Fusion Antibodies | Contract win |
| 12:58 | 19-09-2025 | FAB | Fusion Antibodies | Posting of Annual Report & Notice of AGM |
| 07:00 | 17-09-2025 | FAB | Fusion Antibodies | OptiMAL R&D Update |
| 07:00 | 08-09-2025 | FAB | Fusion Antibodies | Belfast investor presentation |
| 07:00 | 04-09-2025 | FAB | Fusion Antibodies | Final Results |
| 07:00 | 28-08-2025 | FAB | Fusion Antibodies | Contract Win |
| 07:00 | 27-08-2025 | FAB | Fusion Antibodies | Contract wins with existing client |
| 07:00 | 26-08-2025 | FAB | Fusion Antibodies | Investor presentations |
| 07:00 | 05-08-2025 | FAB | Fusion Antibodies | Grant of U.S. Patent for OptiMAL |
| 07:00 | 11-07-2025 | FAB | Fusion Antibodies | Director/PDMR Shareholding |
| 07:00 | 02-06-2025 | FAB | Fusion Antibodies | Total Voting Rights |
| 14:33 | 22-05-2025 | FAB | Fusion Antibodies | Update on U.S. Patent for OptiMAL® |
| 07:00 | 08-05-2025 | FAB | Fusion Antibodies | Investor presentation |
| 07:00 | 07-05-2025 | FAB | Fusion Antibodies | Issue of shares to non-executive directors |
| 10:53 | 06-05-2025 | FAB | Fusion Antibodies | Director/PDMR Shareholding |
| 10:38 | 06-05-2025 | FAB | Fusion Antibodies | Holding(s) in Company |
| 07:00 | 06-05-2025 | FAB | Fusion Antibodies | Trading update |
| 17:00 | 30-04-2025 | FAB | Fusion Antibodies | Total Voting Rights |
| 07:00 | 24-04-2025 | FAB | Fusion Antibodies | Approval of grant funding |
| 10:40 | 11-04-2025 | FAB | Fusion Antibodies | Holding(s) in Company |
| 12:47 | 10-04-2025 | FAB | Fusion Antibodies | Holding(s) in Company |
| 12:35 | 07-04-2025 | FAB | Fusion Antibodies | Result of General Meeting |
| 17:00 | 31-03-2025 | FAB | Fusion Antibodies | Total Voting Rights |
| 16:38 | 24-03-2025 | FAB | Fusion Antibodies | Holding(s) in Company |
| 07:00 | 18-03-2025 | FAB | Fusion Antibodies | Placing to raise approximately £1.17 million |
| 07:00 | 27-02-2025 | FAB | Fusion Antibodies | Contract win |
| 07:00 | 31-01-2025 | FAB | Fusion Antibodies | OptiMAL R&D Update |
| 11:31 | 04-12-2024 | FAB | Fusion Antibodies | Approval of Grant Funding Application |
| 07:00 | 19-11-2024 | FAB | Fusion Antibodies | Half-year Report |
| 13:23 | 16-10-2024 | FAB | Fusion Antibodies | Director/PDMR Shareholding |
| 07:00 | 16-10-2024 | FAB | Fusion Antibodies | Issue of shares to non-executive directors |
| 12:32 | 08-10-2024 | FAB | Fusion Antibodies | Result of AGM |
| 07:00 | 08-10-2024 | FAB | Fusion Antibodies | AGM statement and trading update |
| 07:00 | 02-10-2024 | FAB | Fusion Antibodies | Block admission six monthly return |
| 09:54 | 12-09-2024 | FAB | Fusion Antibodies | Notice of AGM |
| 12:35 | 09-09-2024 | FAB | Fusion Antibodies | Director/PDMR Shareholding |
| 12:15 | 05-09-2024 | FAB | Fusion Antibodies | Director/PDMR Shareholding |
| 07:00 | 05-09-2024 | FAB | Fusion Antibodies | Final Results |
| 12:54 | 22-07-2024 | FAB | Fusion Antibodies | Director/PDMR Shareholding |
| 07:00 | 04-07-2024 | FAB | Fusion Antibodies | Trading update |
| 07:00 | 23-05-2024 | FAB | Fusion Antibodies | New contract with existing client |
| 07:00 | 30-04-2024 | FAB | Fusion Antibodies | Year-end trading statement |
| 14:34 | 02-04-2024 | FAB | Fusion Antibodies | Block admission six monthly return |
| 17:00 | 28-03-2024 | FAB | Fusion Antibodies | Total Voting Rights |
| 15:04 | 11-03-2024 | FAB | Fusion Antibodies | Holding(s) in Company |
| 09:10 | 11-03-2024 | FAB | Fusion Antibodies | Holding(s) in Company |
| 15:09 | 08-03-2024 | FAB | Fusion Antibodies | Holding(s) in Company |
| 10:40 | 05-03-2024 | FAB | Fusion Antibodies | Result of General Meeting and Total Voting Rights |
| 17:00 | 29-02-2024 | FAB | Fusion Antibodies | Total Voting Rights |
| 07:00 | 27-02-2024 | FAB | Fusion Antibodies | First purchase order under MSA |
| 07:15 | 14-02-2024 | FAB | Fusion Antibodies | Grant of options and issue of shares to directors |
| 07:00 | 14-02-2024 | FAB | Fusion Antibodies | Placing to raise £1,375,000 |
| 07:00 | 06-02-2024 | FAB | Fusion Antibodies | Follow-on project award and R&D update |
| 07:00 | 01-02-2024 | FAB | Fusion Antibodies | HMRC R&D tax credit |
| 12:26 | 04-12-2023 | FAB | Fusion Antibodies | Director/PDMR Shareholding |
| 07:00 | 04-12-2023 | FAB | Fusion Antibodies | Half-year Report |
| 07:00 | 28-11-2023 | FAB | Fusion Antibodies | OptiMAL collaboration agreement |
| 07:00 | 09-11-2023 | FAB | Fusion Antibodies | Half year trading update |
| 11:57 | 27-10-2023 | FAB | Fusion Antibodies | Result of AGM |
| 14:45 | 04-10-2023 | FAB | Fusion Antibodies | Block admission six monthly return |
| 07:00 | 29-09-2023 | FAB | Fusion Antibodies | Final Results |
| 07:00 | 29-08-2023 | FAB | Fusion Antibodies | Update on AI/ML-Ab service offering |
| 07:00 | 24-08-2023 | FAB | Fusion Antibodies | Appointment of interim CFO |
| 07:00 | 21-08-2023 | FAB | Fusion Antibodies | Update on AI/ML-Ab™ antibody discovery service |
| 07:00 | 14-08-2023 | FAB | Fusion Antibodies | Update on restructure and cost savings |
| 17:00 | 30-06-2023 | FAB | Fusion Antibodies | Total Voting Rights |
| 10:09 | 16-06-2023 | FAB | Fusion Antibodies | Holding(s) in Company |
| 09:45 | 15-06-2023 | FAB | Fusion Antibodies | Holding(s) in Company |
| 14:44 | 13-06-2023 | FAB | Fusion Antibodies | Holding(s) in Company |
| 15:34 | 12-06-2023 | FAB | Fusion Antibodies | Holding(s) in Company |
| 11:02 | 12-06-2023 | FAB | Fusion Antibodies | Director/PDMR Shareholding |
| 10:39 | 08-06-2023 | FAB | Fusion Antibodies | Result of GM and total voting rights |
| 17:00 | 31-05-2023 | FAB | Fusion Antibodies | Total Voting Rights |
| 16:57 | 26-05-2023 | FAB | Fusion Antibodies | Holding(s) in Company |
| 13:33 | 26-05-2023 | FAB | Fusion Antibodies | Holding(s) in Company |
| 07:00 | 23-05-2023 | FAB | Fusion Antibodies | Result of Retail Offer and Notice of GM |
| 10:01 | 19-05-2023 | FAB | Fusion Antibodies | REX Retail Offer |
| 10:00 | 19-05-2023 | FAB | Fusion Antibodies | Placing, Subscription and Retail Offer |